DL-1,2-Isopropylideneglycerol

We are DL-1,2-Isopropylideneglycerol CAS:100-79-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:DL-1,2-Isopropylideneglycerol
CAS.NO:100-79-8
Synonyms:DL-1,2-Isopropylideneglycerol
(±)-2,2-Dimethyl-4-hydroxymethyl-1,3-dioxolane
1,2-Isopropylideneglycerol
1,3-Dioxolane-4-methanol, 2,2-dimethyl-
2,2-Dimethyl-1,3-dioxolane-4-methanol
Solketal
Molecular Formula:C6H12O3
Molecular Weight:132.15800
 
Physical and Chemical Properties:
Density:1.063
Boiling point:188-189ºC
Flash point:80ºC
Index of Refraction:1.433-1.435
 
Specification:
Appearance:Colorless liquid
Assay:≥97.0%
 
Packing:180 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It is an important organic synthesis intermediate, which can be used as a solvent, plasticizer, pharmaceutical excipients, etc.

DL-1,2-Isopropylideneglycerol


Related News: This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.?1-chloro-10-iododecane CAS:57152-87-1 After testing, our quality assurance staff confirms that everything has been performed correctly in accordance with GMP from manufacturing of API to quality testing.7-hydroxy-1H-quinolin-2-one CAS:70500-72-0 After testing, our quality assurance staff confirms that everything has been performed correctly in accordance with GMP from manufacturing of API to quality testing.39741-41-8 With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand.China has granted conditional approval to its first self-developed treatment for Alzheimer’s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug.

Related Products
Product Name
2-Chloro-4-picoline View Details
N-[3-[1-(dimethylamino)-3-oxoprop-1-en-2-yl]phenyl]acetamide View Details
methyl (3S)-3-amino-3-phenylpropanoate,hydrochloride View Details
2-Butyl Octanedioic acid manufacturer (2S)-2-amino-3-(4-nitrophenyl)propanoic acid,hydrate manufacturer Octachlorocyclopentene manufacturer 4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine manufacturer (1R,2R)-Cyclohexane-1,2-diyldimethanol manufacturer